Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| epithelial cell | 4 studies | 26% ± 6% | |
| oligodendrocyte | 4 studies | 20% ± 2% | |
| ciliated cell | 3 studies | 28% ± 3% | |
| GABAergic neuron | 3 studies | 27% ± 8% | |
| glutamatergic neuron | 3 studies | 37% ± 6% | |
| basal cell | 3 studies | 22% ± 6% | |
| astrocyte | 3 studies | 27% ± 3% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 4 studies | 28% ± 1% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| breast | 100% | 1241.07 | 459 / 459 | 100% | 27.56 | 1118 / 1118 |
| kidney | 100% | 951.47 | 89 / 89 | 100% | 19.47 | 901 / 901 |
| prostate | 100% | 1325.36 | 245 / 245 | 100% | 21.56 | 502 / 502 |
| brain | 100% | 840.96 | 2635 / 2642 | 100% | 12.63 | 705 / 705 |
| thymus | 100% | 1417.08 | 653 / 653 | 100% | 16.99 | 603 / 605 |
| adrenal gland | 100% | 1869.25 | 258 / 258 | 100% | 19.36 | 229 / 230 |
| ovary | 100% | 1177.05 | 180 / 180 | 100% | 10.24 | 428 / 430 |
| lung | 99% | 1077.60 | 575 / 578 | 100% | 15.43 | 1155 / 1155 |
| esophagus | 100% | 1133.69 | 1445 / 1445 | 99% | 15.01 | 182 / 183 |
| uterus | 100% | 1500.65 | 170 / 170 | 99% | 15.98 | 456 / 459 |
| liver | 100% | 1016.80 | 226 / 226 | 99% | 10.38 | 403 / 406 |
| pancreas | 100% | 993.30 | 327 / 328 | 99% | 14.05 | 177 / 178 |
| bladder | 100% | 1199.29 | 21 / 21 | 99% | 15.15 | 498 / 504 |
| intestine | 100% | 1309.21 | 966 / 966 | 97% | 13.13 | 513 / 527 |
| stomach | 100% | 1021.56 | 359 / 359 | 97% | 12.27 | 277 / 286 |
| skin | 100% | 1302.35 | 1807 / 1809 | 93% | 12.34 | 440 / 472 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 10.08 | 29 / 29 |
| spleen | 100% | 1152.47 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 15.81 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 8.80 | 1 / 1 |
| adipose | 100% | 1101.25 | 1203 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 100% | 1212.51 | 1333 / 1335 | 0% | 0 | 0 / 0 |
| heart | 99% | 892.96 | 853 / 861 | 0% | 0 | 0 / 0 |
| muscle | 98% | 500.47 | 786 / 803 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 70% | 4.97 | 56 / 80 |
| peripheral blood | 70% | 594.50 | 649 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0050688 | Biological process | regulation of defense response to virus |
| GO_0051607 | Biological process | defense response to virus |
| GO_0016020 | Cellular component | membrane |
| GO_0005096 | Molecular function | GTPase activator activity |
| Gene name | ELMOD2 |
| Protein name | ELMO domain containing 2 ELMO domain-containing protein 2 |
| Synonyms | |
| Description | FUNCTION: Acts as a GTPase-activating protein (GAP) toward guanine nucleotide exchange factors like ARL2, ARL3, ARF1 and ARF6, but not for GTPases outside the Arf family. Regulates IFN-related antiviral responses. . |
| Accessions | ENST00000507667.1 D6RHX2 ENST00000511887.6 Q8IZ81 ENST00000513606.1 ENST00000502397.5 V9GY58 ENST00000323570.8 D6RJB5 D6RBS5 |
